Clinical Trials Sponsored by i3 Innovus

Total 113 results

AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
AstraZeneca
i3 Innovus

Completed

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Spain, United Kingdom
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Otsuka Pharmaceutical Development & Commercialization...
i3 Innovus

Completed

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Depressive Disorder, Major
Pharmaxis
i3 Research

Completed

Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma

Allergic Asthma

United Kingdom
Innovus Pharmaceuticals, Inc.

Unknown

An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

Healthy Aging

United States
Innovus Pharmaceuticals, Inc.

Unknown

A Study to Evaluate the Effect and Tolerance of Musclin™ (Thymol) in Healthy Subjects

Healthy Volunteers

United States
GE Healthcare
Quintiles, Inc.; Medpace, Inc.; i3 Statprobe; i3 Research

Completed

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Mild Cognitive Impairment | Alzheimer's Disease

United States
GE Healthcare
i3 Statprobe

Completed

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Renal Insufficiency | Chronic Kidney Disease

United States
GE Healthcare
i3 Statprobe

Completed

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Patient Comfort and Safety

United States
GE Healthcare
i3 Statprobe

Completed

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms

Parkinsonian Syndromes

United States, France
GE Healthcare
i3 Statprobe

Completed

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Drug Safety

United States
GE Healthcare
i3 Statprobe

Terminated

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus

United States
GE Healthcare
i3 Statprobe

Completed

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus

United States
Noscira SA
i3 Research

Completed

Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy (Tauros)

Progressive Supranuclear Palsy

United States, Germany, Spain, United Kingdom
GE Healthcare
Covance; i3 Statprobe

Completed

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Brain Fibrillarab Levels

United States
AltheaDx
Innovis LLC

Completed

Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety

Depression | Anxiety

United States
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Healthy

United States
Epigenomics, Inc
Innovis LLC

Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Cirrhosis, Liver | Liver Cancer | Hepatic Cirrhosis

United States
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Healthy

United States
InnFocus Inc.

Completed

PRESERFLO® MicroShunt Extension Study

Primary Open-angle Glaucoma

Spain, United States, United Kingdom, France, Italy
Innovis LLC
Ajinomoto Co., Inc.

Completed

A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

Lung Cancer

United States
Eli Lilly and Company
i3 Drug Safety

Completed

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Transient Ischemic Attack | ADHD | Cerebrovascular Accident

United States
InnFocus Inc.

Completed

InnFocus MicroShunt Versus Trabeculectomy Study (IMS)

Primary Open Angle Glaucoma

Spain, United States, United Kingdom, France, Netherlands, Italy
InnFocus Inc.

Completed

Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms

Glaucoma

Dominican Republic
InnFocus Inc.

Completed

Post Market Study of the InnFocus MicroShunt

Primary Open Angle Glaucoma

France, Netherlands, Spain, Switzerland
InnFocus Inc.

Completed

Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant

Primary Open Angle Glaucoma

France
AstraZeneca
Eli Lilly and Company; i3 Drug Safety

Completed

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)

United States
Innovis LLC
Exact Sciences Corporation

Recruiting

Vaginal Fluid Collection for Detection of Endometrial Cancer

Endometrial Cancer

United States
Innovis LLC
Exact Sciences Corporation

Recruiting

Stool Sample Collection Study

Colorectal Cancer

United States
Benovus Bio, Inc.

Unknown

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer (BBMPI03)

Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Multiple Myeloma (MM) | Smoldering Multiple Myeloma (sMM)

United States
Annovis Bio Inc.

Terminated

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Alzheimer's Disease | Amnestic Mild Cognitive Impairment

United States
Annovis Bio Inc.

Completed

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Alzheimer Disease

United States
Pfizer
Innovex, Inc

Completed

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

Rheumatoid Arthritis

Luxembourg
Innovo Therapeutics, Inc.

Recruiting

Ointment to Prevent Scar After Thyroidectomy

Scar

Korea, Republic of
Innovo Therapeutics, Inc.

Completed

First in Human, Single Ascending Dose Study

Ulcerative Colitis

Korea, Republic of
GE Healthcare
Hvidovre University Hospital; Medpace, Inc.; i3 Statprobe

Completed

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers (ALZ201)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment

Norway
Novus Scientific

Completed

Safety and Performance Study of TIGR Matrix Surgical Mesh in Inguinal Hernia Repair

Inguinal Hernia

Sweden
Innova Vascular, Inc.

Not yet recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (TRUST)

Pulmonary Embolism
InnoUp Farma S.L.

Unknown

Oral Immunotherapy for Peanut Allergic Patients

Peanut Allergy

Spain
Annovis Bio Inc.
Parexel

Completed

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

Parkinson Disease | Alzheimer Disease

United States
Bio-innova Co., Ltd

Not yet recruiting

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

Healthy Subjects
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Bio-innova Co., Ltd

Not yet recruiting

Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Healthy Subjects
University of Dundee
Tenovus Scotland

Completed

Beta Blocker Therapy in Moderate to Severe COPD (ANDA2)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Dundee
Tenovus Scotland

Completed

Ultra-long Acting Bronchodilator Therapy in Asthmatics (MAN02)

Asthma

United Kingdom

Clinical Trials Sponsored by i3 Innovus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations